Beyond the Abstract - Usefulness of new schemes to group Fuhrman grades in clinical practice for clear cell renal tumour, by Eduardo Morán Pascual

BERKELEY, CA (UroToday.com) - Renal tumor is the third urological neoplasm in frequency after prostate cancer and bladder cancer.

To read more, a FREE Urotoday registration is required. Click here to register or login above.
To read UIJ content, a separate subscription is required.